Oklahoma 2022 Regular Session

Oklahoma Senate Bill SB459 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1	1
2	2
3		-	SB459 HFLR Page 1
4		-	BOLD FACE denotes Committee Amendments. 1
	3	+	ENGR. S. B. NO. 459 Page 1 1
5	4		2
6	5		3
7	6		4
8	7		5
9	8		6
10	9		7
11	10		8
12	11		9
13	12		10
14	13		11
15	14		12
16	15		13
17	16		14
18	17		15
19	18		16
20	19		17
21	20		18
22	21		19
23	22		20
24	23		21
25	24		22
26	25		23
27	26		24
28		-
29		-	HOUSE OF REPRESENTATIVES - FLOOR VERSION
30		-
31		-	STATE OF OKLAHOMA
32		-
33		-	1st Session of the 58th Legislature (2021)
34	27
35	28		ENGROSSED SENATE
36	29		BILL NO. 459 By: Paxton of the Senate
37	30
38	31		and
39	32
40	33		Burns of the House
41	34
42	35
43	36
44	37
45	38		An Act relating to workplace drug and alcohol
46	39		procedures; amending 40 O.S. 2011, Section 552, as
47	40		last amended by Section 24, Chapter 11, O.S.L. 2019
48	41		(40 O.S. Supp. 2020, Section 552), which relates to
49	42		definitions; modifying definition ; including certain
50	43		volunteers; amending Section 2, Chapter 11, O.S.L.
51	44		2019, as last amended by Section 48, Chapter 161,
52	45		O.S.L. 2020 (63 O.S. Supp. 2020, Section 427. 2),
53	46		which relates to definitions; adding definitions;
54	47		including certain applicants, employees and
55	48		volunteers; amending Section 8, Chapter 11, O.S.L.
56	49		2019 (63 O.S. Supp. 2020, Section 427.8), which
57	50		relates to additional rights of medical marijuana
58	51		patients; modifying safety-sensitive positions;
59	52		updating statutory referenc es; and providing an
60	53		effective date.
61	54
62	55
63	56
64	57
65	58		BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
66	59		SECTION 1. AMENDATORY 40 O.S. 2011, Section 552, as last
67	60		amended by Section 24, Chapter 11, O.S.L. 2019 (40 O.S. Supp. 2020,
68	61		Section 552), is amended to read as follows:
69	62		Section 552. As used in the Standards for Workplace Drug and
70	63		Alcohol Testing Act:
	64	+	1. “Alcohol” means ethyl alcohol or ethanol;
	65	+	2. “Applicant” means a person who has applied for a position
	66	+	with an employer and received a conditional offe r of employment or a
71	67
72		-	SB459 HFLR Page 2
73		-	BOLD FACE denotes Committee Amendments. 1
	68	+	ENGR. S. B. NO. 459 Page 2 1
74	69		2
75	70		3
76	71		4
77	72		5
78	73		6
79	74		7
80	75		8
81	76		9
82	77		10
83	78		11
84	79		12
85	80		13
86	81		14
87	82		15
88	83		16
89	84		17
90	85		18
91	86		19
92	87		20
93	88		21
94	89		22
95	90		23
96	91		24
97	92
98		-	1. “Alcohol” means ethyl alcohol or ethanol;
99		-	2. “Applicant” means a person who has applied for a position
100		-	with an employer and received a conditional offer of employment or a
101	93		person who seeks to supply services or labor in a safety s ensitive
102	94		position as defined in Section 427.8 of Title 63 of the Oklahoma
103	95		Statutes to an organization;
104	96		3. “Board” means the State Board of Health;
105	97		4. “Confirmation test” means a drug or alcohol test on a sample
106	98		to substantiate the results of a pri or drug or alcohol test on the
107	99		same sample and which uses different chemical principles and i s of
108	100		equal or greater accuracy than the prior drug or alcohol test.
109	101		Where a breathalyzer test is util ized, a confirmation test means a
110	102		second sample test that con firms the prior result. Where a single-
111	103		use test is utilized, a confirmation test means a sec ond test
112	104		confirmed by a testing facility. A breath or blood specimen may be
113	105		used for the confirmation test for alcohol. A urine, saliva or
114	106		blood specimen may be used for the confirmation test for drugs;
115	107		5. “Department” means the State Department of Heal th;
116	108		6. “Drug” means amphetamines, cannabinoids, cocaine,
117	109		phencyclidine (PCP), h allucinogens, methaqua lone, opiates,
118	110		barbiturates, benzodiazepines, synthetic narco tics, designer drugs,
119	111		or a metabolite of any of the substances listed herein;
120	112		7. “Drug or alcohol test” means a chemical test administered
121	113		for the purpose of determining th e presence or absence of a drug or
	114	+	its metabolites or alcohol in a person ’s bodily tissue, fluids or
	115	+	products. Adulteration of a specimen or of a drug or alcohol test
	116	+	shall be considered as a refusal to test;
122	117
123		-	SB459 HFLR Page 3
124		-	BOLD FACE denotes Committee Amendments. 1
	118	+	ENGR. S. B. NO. 459 Page 3 1
125	119		2
126	120		3
127	121		4
128	122		5
129	123		6
130	124		7
131	125		8
132	126		9
133	127		10
134	128		11
135	129		12
136	130		13
137	131		14
138	132		15
139	133		16
140	134		17
141	135		18
142	136		19
143	137		20
144	138		21
145	139		22
146	140		23
147	141		24
148	142
149		-	its metabolites or alcohol in a person ’s bodily tissue, fluids or
150		-	products. Adulteration of a specimen or of a drug or alcohol test
151		-	shall be considered as a refusal to test;
152	143		8. “Employee” means any person who supplies l abor for
153	144		remuneration to his or her employer in this state and shall not
154	145		include an independe nt contractor, subcontractor or, employees of an
155	146		independent contractor or volunteer; provided, however, an
156	147		independent contractor, subcontractor , or employees of an
157	148		independent contractor, may be subject to a workplace drug or
158	149		alcohol testing policy under the terms of the contractual agreement
159	150		when the drug or alcohol test ing policy applies to other w orkers at
160	151		the job site or workers who are in the same or similar
161	152		classification or group, and a volunteer who supplies volunteer
162	153		services or labor in a safety-sensitive position as defined by
163	154		Section 427.8 of Title 63 of the Oklahoma Statutes to an
164	155		organization may be subject to a workplace drug and alcohol testing
165	156		policy under the terms of the organization’s policy;
166	157		9. “Employer” means any person, firm, corpo ration, partnership,
167	158		association, nonprofit organization or public employer, which has
168	159		one or more employees within this state, or which has offered or may
169	160		offer employment or volunteer opportunities in safety-sensitive
170	161		positions as defined by Section 427. 8 of Title 63 of the Oklahoma
171	162		Statutes to one or more individuals in this state;
	163	+	10. “Public employer” means the State of Oklahoma or any
	164	+	political subdivision thereof, including any d epartment, agency,
	165	+	board, commission, institution, authority, pub lic trust,
	166	+	municipality, county, district or instrumentalities thereof;
172	167
173		-	SB459 HFLR Page 4
174		-	BOLD FACE denotes Committee Amendments. 1
	168	+	ENGR. S. B. NO. 459 Page 4 1
175	169		2
176	170		3
177	171		4
178	172		5
179	173		6
180	174		7
181	175		8
182	176		9
183	177		10
184	178		11
185	179		12
186	180		13
187	181		14
188	182		15
189	183		16
190	184		17
191	185		18
192	186		19
193	187		20
194	188		21
195	189		22
196	190		23
197	191		24
198	192
199		-	10. “Public employer” means the State of Oklahoma or any
200		-	political subdivision thereof, including any department, agency,
201		-	board, commission, institution, authority, public trust,
202		-	municipality, county, district or instrumentalities thereof;
203	193		11. “Review officer” means a person, qualified by the State
204	194		Board of Health, who is responsible for receiving results from a
205	195		testing facility which have been generated by an employer ’s drug or
206	196		alcohol testing program, and who has knowledge and training to
207	197		interpret and evaluate an individual’s test results together with
208	198		the individual’s medical history and any other relev ant information;
209	199		12. “Sample” means tissue, fluid or product of the human body
210	200		chemically capable of revealing the presence of drugs or alcohol in
211	201		the human body; and
212	202		13. “Testing facility” means a facility which provides
213	203		laboratory services to test samp les for the presence of drugs or
214	204		alcohol.
215	205		SECTION 2. AMENDATORY Section 2, Chapter 11, O.S.L.
216	206		2019, as last amended by Section 48, Chapter 161, O.S.L. 2020 (63
217	207		O.S. Supp. 2020, Section 427.2), is amended to read as follow s:
218	208		Section 427.2. As used in this act the Oklahoma Medical
219	209		Marijuana and Patient Protection Act :
220	210		1. “Advertising” means the act of providing consider ation for
221	211		the publication, dissemination, solicitation, or circulation, of
222	212		visual, oral, or written communication to induce directly or
	213	+	indirectly any perso n to patronize a particular medical marijuana
	214	+	business, or to purchase particular medical marijuana or a medical
	215	+	marijuana product. Advertising includes marketing, but does not
	216	+	include packaging and labeling;
223	217
224		-	SB459 HFLR Page 5
225		-	BOLD FACE denotes Committee Amendments. 1
	218	+	ENGR. S. B. NO. 459 Page 5 1
226	219		2
227	220		3
228	221		4
229	222		5
230	223		6
231	224		7
232	225		8
233	226		9
234	227		10
235	228		11
236	229		12
237	230		13
238	231		14
239	232		15
240	233		16
241	234		17
242	235		18
243	236		19
244	237		20
245	238		21
246	239		22
247	240		23
248	241		24
249	242
250		-	indirectly any person to patronize a particular medical marij uana
251		-	business, or to purchase particular medical marijuana or a medical
252		-	marijuana product. Advertising includes marketing, but does not
253		-	include packaging and labeling;
254	243		2. “Applicant” means a person who has applied for a position
255	244		with an employer and received a conditional offe r of employment or a
256	245		person who seeks to supply services or labor in a safety-sensitive
257	246		position as defined in Section 427.8 of this title to an
258	247		organization;
259	248		3. “Authority” means the Oklahoma Medical Mar ijuana Authority;
260	249		3. 4. “Batch number” means a unique numeric or alphanumeric
261	250		identifier assigned prior to testing to allow for inventory tracking
262	251		and traceability;
263	252		4. 5. “Cannabinoid” means any of the chemical compounds that
264	253		are active principles of marijuana ;
265	254		5. 6. “Caregiver” means a family member or assistant who
266	255		regularly looks after a medical marijuana license holder whom a
267	256		physician attests needs assistance;
268	257		6. 7. “Child-resistant” means special packaging that is:
269	258		a. designed or constructed to be significant ly difficult
270	259		for children under five (5) years of age to open and
271	260		not difficult for normal adults to use properly as
272	261		defined by 16 C.F.R. 1700.15 (1995) and 16 C.F.R.
273	262		1700.20 (1995),
	263	+	b. opaque so that the outermost packaging does not allow
	264	+	the product to be seen without opening the packaging
	265	+	material, and
274	266
275		-	SB459 HFLR Page 6
276		-	BOLD FACE denotes Committee Amendments. 1
	267	+	ENGR. S. B. NO. 459 Page 6 1
277	268		2
278	269		3
279	270		4
280	271		5
281	272		6
282	273		7
283	274		8
284	275		9
285	276		10
286	277		11
287	278		12
288	279		13
289	280		14
290	281		15
291	282		16
292	283		17
293	284		18
294	285		19
295	286		20
296	287		21
297	288		22
298	289		23
299	290		24
300	291
301		-	b. opaque so that the outermost packaging does not allow
302		-	the product to be seen without o pening the packaging
303		-	material, and
304	292		c. resealable to maintai n its child-resistant
305	293		effectiveness for multiple openings for any product
306	294		intended for more than a single use or containing
307	295		multiple servings;
308	296		7. 8. “Clone” means a nonflowering plant cut from a mother
309	297		plant that is capable of developing into a new plant and has shown
310	298		no signs of flowering;
311	299		8. 9. “Commissioner” means the State Commissioner of Health;
312	300		9. 10. “Complete application ” means a document prepared in
313	301		accordance with the provisions s et forth in this act the Oklahoma
314	302		Medical Marijuana and Patient Protection Act, rules promulgated
315	303		pursuant thereto, and the forms and i nstructions provided by the
316	304		Department, including any supporting documentation required and the
317	305		applicable license application fee;
318	306		10. 11. “Department” means the State Department of Health;
319	307		11. 12. “Director” means the Executive Director of the Oklahoma
320	308		Medical Marijuana Authority;
321	309		12. 13. “Dispense” means the selling of medical marijuana or a
322	310		medical marijuana product to a qualified patient or the designated
323	311		caregiver of the patient that is packaged in a suitable container
	312	+	appropriately labeled for subseq uent administration to or use by a
	313	+	qualifying patient;
	314	+	13. 14. “Dispensary” means a medical marijuana dispensary, an
	315	+	entity that has been licensed by the Department pursuant to this act
324	316
325		-	SB459 HFLR Page 7
326		-	BOLD FACE denotes Committee Amendments. 1
	317	+	ENGR. S. B. NO. 459 Page 7 1
327	318		2
328	319		3
329	320		4
330	321		5
331	322		6
332	323		7
333	324		8
334	325		9
335	326		10
336	327		11
337	328		12
338	329		13
339	330		14
340	331		15
341	332		16
342	333		17
343	334		18
344	335		19
345	336		20
346	337		21
347	338		22
348	339		23
349	340		24
350	341
351		-	appropriately labeled for subsequent administration to or use by a
352		-	qualifying patient;
353		-	13. 14. “Dispensary” means a medical marijuana dispensary, an
354		-	entity that has been licensed by the Department pursuant to this act
355	342		the Oklahoma Medical Marijuana and Patient Protection Act to
356	343		purchase medical marijuana or medical marijuana prod ucts from a
357	344		licensed medical marijuana commercial grower or medical marijuana
358	345		processor, sell medical marijuana or medical marijuana products to
359	346		patients and caregivers as defined under this act the Oklahoma
360	347		Medical Marijuana and Patient Protection Act , or sell or transfer
361	348		products to another dispensary;
362	349		14. 15. “Edible medical marijuana product” means any medical-
363	350		marijuana-infused product for which the intended use i s oral
364	351		consumption including, but not limited to, any type of food, drink
365	352		or pill;
366	353		16. “Employee” means any person who supplies labor for
367	354		remuneration to his or he r employer in this state and shall not
368	355		include an independent contractor , subcontractor, employees of an
369	356		independent contractor or volunteer; provided, however, an
370	357		independent contractor, sub contractor or employees of an independent
371	358		contractor, may be s ubject to a workplace drug or alcohol testing
372	359		policy under the terms of the cont ractual agreement when the drug or
373	360		alcohol testing policy applies to other workers at the job site or
374	361		workers who are in the same or similar cl assification or group, and
	362	+	a volunteer who supplies volunteer services or labor in a safety-
	363	+	sensitive position as defined by Section 427.8 of this title to an
	364	+	organization may be subject to a work place drug and alcohol testing
	365	+	policy under the terms of the organizat ion’s policy;
375	366
376		-	SB459 HFLR Page 8
377		-	BOLD FACE denotes Committee Amendments. 1
	367	+	ENGR. S. B. NO. 459 Page 8 1
378	368		2
379	369		3
380	370		4
381	371		5
382	372		6
383	373		7
384	374		8
385	375		9
386	376		10
387	377		11
388	378		12
389	379		13
390	380		14
391	381		15
392	382		16
393	383		17
394	384		18
395	385		19
396	386		20
397	387		21
398	388		22
399	389		23
400	390		24
401	391
402		-	a volunteer who supplies volunteer services or labor in a safety -
403		-	sensitive position as defined by Section 427.8 of this title to an
404		-	organization may be subject to a workplace drug and alcohol testing
405		-	policy under the terms of the organization ’s policy;
406	392		15. 17. “Entity” means an individual, general partnership,
407	393		limited partnership, limited liability co mpany, trust, estate,
408	394		association, corporation, cooperative , or any other legal or
409	395		commercial entity;
410	396		16. 18. “Flower” means the reproductive organs of the marijuana
411	397		or cannabis plant referred to as the bud or parts of the plant that
412	398		are harvested and use d to consume in a variety of medical marijuana
413	399		products;
414	400		17. 19. “Flowering” means the reproductive s tate of the
415	401		marijuana or cannabis plant in which there are physical signs of
416	402		flower or budding out of the nodes of the stem;
417	403		18. 20. “Food-based medical marijuana concentrate” means a
418	404		medical marijuana concentrate that was produced by extracting
419	405		cannabinoids from medical marijuana through the use of propylene
420	406		glycol, glycerin, butter, olive oil, coconut oil or other typical
421	407		food-safe cooking fats;
422	408		19. 21. “Good cause” for purposes of an initial, renewal or
423	409		reinstatement license application, or for purpose s of discipline of
424	410		a licensee, means:
	411	+	a. the licensee or applicant has violated, does not me et,
	412	+	or has failed to comply with any of the terms,
	413	+	conditions or provisions of the act Oklahoma Medical
	414	+	Marijuana and Patient Protection Act , any rules
425	415
426		-	SB459 HFLR Page 9
427		-	BOLD FACE denotes Committee Amendments. 1
	416	+	ENGR. S. B. NO. 459 Page 9 1
428	417		2
429	418		3
430	419		4
431	420		5
432	421		6
433	422		7
434	423		8
435	424		9
436	425		10
437	426		11
438	427		12
439	428		13
440	429		14
441	430		15
442	431		16
443	432		17
444	433		18
445	434		19
446	435		20
447	436		21
448	437		22
449	438		23
450	439		24
451	440
452		-	a. the licensee or applicant has violated, does not meet,
453		-	or has failed to comply with any of the terms,
454		-	conditions or provisions of the act Oklahoma Medical
455		-	Marijuana and Patient Protection Act , any rules
456	441		promulgated pursuant thereto, or any supplemental
457	442		relevant state or local law, rule or regulation,
458	443		b. the licensee or applicant has failed to comply with
459	444		any special terms or conditions that were placed upon
460	445		the license pursuant to an order of the State
461	446		Department of Health, Oklahoma Medical Marijuana
462	447		Authority or the municipality, or
463	448		c. the licensed premises of a medical marijuana business
464	449		or applicant have be en operated in a manner that
465	450		adversely affects the public heal th or welfare or the
466	451		safety of the immediate vicinity in which the
467	452		establishment is located;
468	453		20. 22. “Harvest batch” means a specifically identifi ed
469	454		quantity of medical marijuana that is uniform in strain, cultivated
470	455		utilizing the same cultivation practic es, harvested at the same time
471	456		from the same location and cured under uniform conditions;
472	457		21. 23. “Harvested marijuana” means post-flowering medical
473	458		marijuana not including trim, concentrate or waste;
474	459		22. 24. “Heat- or pressure-based medical marijuana co ncentrate”
475	460		means a medical marijuana concentrate that was produced by
	461	+	extracting cannabinoids from med ical marijuana through the use of
	462	+	heat or pressure;
	463	+	23. 25. “Immature plant” means a nonflowering mariju ana plant
	464	+	that has not demonstrated signs of flow ering;
476	465
477		-	SB459 HFLR Page 10
478		-	BOLD FACE denotes Committee Amendments. 1
	466	+	ENGR. S. B. NO. 459 Page 10 1
479	467		2
480	468		3
481	469		4
482	470		5
483	471		6
484	472		7
485	473		8
486	474		9
487	475		10
488	476		11
489	477		12
490	478		13
491	479		14
492	480		15
493	481		16
494	482		17
495	483		18
496	484		19
497	485		20
498	486		21
499	487		22
500	488		23
501	489		24
502	490
503		-	extracting cannabinoids from medical marijuana th rough the use of
504		-	heat or pressure;
505		-	23. 25. “Immature plant” means a nonflowering marijuana plant
506		-	that has not demonstrated signs of flowering;
507	491		24. 26. “Inventory tracking system” means the required tracking
508	492		system that accounts for medic al marijuana from either the seed or
509	493		immature plant stage until the medical marijuana or medical
510	494		marijuana product is sold to a patient at a medical marij uana
511	495		dispensary, transferred to a medical marijuana research facility,
512	496		destroyed by a medical marijuan a business or used in a research
513	497		project by a medical marijuana research facility;
514	498		25. 27. “Licensed patient” or “patient” means a person who has
515	499		been issued a medical marijuana patient license by the State
516	500		Department of Health or Oklahoma Medical Marijua na Authority;
517	501		26. 28. “Licensed premises” means the premises specified in an
518	502		application for a medical m arijuana business license, medical
519	503		marijuana research facility license or medical marijuana education
520	504		facility license pursuant to this act the Oklahoma Medical Marijuana
521	505		and Patient Protection Act that are owned or in possession of the
522	506		licensee and within which the licensee is authorized to cultivate,
523	507		manufacture, distribute, sell, store, transport, test or re search
524	508		medical marijuana or medical marijuana products in accordance with
525	509		the provisions of this act the Oklahoma Medical Marijuana and
526	510		Patient Protection Act and rules promulgated pursuant thereto;
	511	+	27. 29. “Manufacture” means the production, propagation,
	512	+	compounding or processing o f a medical marijuana product, excluding
	513	+	marijuana plants, either directly or indirectly by extraction from
	514	+	substances of natural or synthetic origin, or independently by means
527	515
528		-	SB459 HFLR Page 11
529		-	BOLD FACE denotes Committee Amendments. 1
	516	+	ENGR. S. B. NO. 459 Page 11 1
530	517		2
531	518		3
532	519		4
533	520		5
534	521		6
535	522		7
536	523		8
537	524		9
538	525		10
539	526		11
540	527		12
541	528		13
542	529		14
543	530		15
544	531		16
545	532		17
546	533		18
547	534		19
548	535		20
549	536		21
550	537		22
551	538		23
552	539		24
553	540
554		-	27. 29. “Manufacture” means the production, propagation,
555		-	compounding or processing of a medical marijuana product, ex cluding
556		-	marijuana plants, either directly or indirectly by extraction from
557		-	substances of natural or synthetic origin, or independently by means
558	541		of chemical synthesis, or by a combination of extraction and
559	542		chemical synthesis;
560	543		28. 30. “Marijuana” shall have the same meaning as such term is
561	544		defined in Section 2 -101 of Title 63 of the Oklahoma S tatutes this
562	545		title;
563	546		29. 31. “Material change” means any change that would r equire a
564	547		substantive revision to the standard operating procedures of a
565	548		licensee for the cultivation or production of medical marijuana,
566	549		medical marijuana concentrate or medical ma rijuana products;
567	550		30. 32. “Mature plant” means a harvestable female marijuan a
568	551		plant that is flowering;
569	552		31. 33. “Medical marijuana business (MMB) ” means a licensed
570	553		medical marijuana dispensary, medical marijuana processor, medical
571	554		marijuana commercial gro wer, medical marijuana laboratory, me dical
572	555		marijuana business operator , or a medical marijuana transporter;
573	556		32. 34. “Medical marijuana concentrate ” or “concentrate” means
574	557		a specific subset of medical marijuana that was produced by
575	558		extracting cannabinoids from medical marijuana. Categories of
576	559		medical marijuana concentrate include wa ter-based medical marijuana
577	560		concentrate, food-based medical marijuana concentrate, sol vent-based
	561	+	medical marijuana concentrate, and heat - or pressure-based medical
	562	+	marijuana concentrate;
	563	+	33. 35. “Medical marijuana commercial grower” or “commercial
	564	+	grower” means an entity licensed to cultivate, prepare and package
578	565
579		-	SB459 HFLR Page 12
580		-	BOLD FACE denotes Committee Amendments. 1
	566	+	ENGR. S. B. NO. 459 Page 12 1
581	567		2
582	568		3
583	569		4
584	570		5
585	571		6
586	572		7
587	573		8
588	574		9
589	575		10
590	576		11
591	577		12
592	578		13
593	579		14
594	580		15
595	581		16
596	582		17
597	583		18
598	584		19
599	585		20
600	586		21
601	587		22
602	588		23
603	589		24
604	590
605		-	medical marijuana concentrate, and heat - or pressure-based medical
606		-	marijuana concentrate;
607		-	33. 35. “Medical marijuana commercial grower ” or “commercial
608		-	grower” means an entity licensed to cultivate, prepare and package
609	591		medical marijuana and tran sfer or contract for transfer medical
610	592		marijuana to a medical marijuana dispensary, medical marijuana
611	593		processor, any other medical marijuana commercial grower, medical
612	594		marijuana research facility, medical marijuana education facility
613	595		and pesticide manufactu rers. A commercial grower may sell seeds,
614	596		flower or clones to commercial growers pursuant to this act the
615	597		Oklahoma Medical Marijuana and P atient Protection Act ;
616	598		34. 36. “Medical marijuana education facility ” or “education
617	599		facility” means a person or entity approv ed pursuant to this act the
618	600		Oklahoma Medical Marijuana and Patient Protection Act to operate a
619	601		facility providing training and education to individuals involving
620	602		the cultivation, growing, harvesting, curing, preparing, packaging
621	603		or testing of medical marijuana, or the production, manufacture,
622	604		extraction, processing, packaging or creatio n of medical-marijuana-
623	605		infused products or medical marijua na products as described in this
624	606		act the Oklahoma Medical Marijuana and Patient Protection Act ;
625	607		35. 37. “Medical-marijuana-infused product” means a product
626	608		infused with medical marijuana including, but not limited to, edible
627	609		products, ointments and tinctures;
	610	+	36. 38. “Medical marijuana product ” or “product” means a
	611	+	product that contains cannabinoids that have been extracted from
	612	+	plant material or the resin therefrom by physical or chemical means
	613	+	and is intended for administration to a qualified patient including,
	614	+	but not limited to, oils, tinctur es, edibles, pills, topical forms,
628	615
629		-	SB459 HFLR Page 13
630		-	BOLD FACE denotes Committee Amendments. 1
	616	+	ENGR. S. B. NO. 459 Page 13 1
631	617		2
632	618		3
633	619		4
634	620		5
635	621		6
636	622		7
637	623		8
638	624		9
639	625		10
640	626		11
641	627		12
642	628		13
643	629		14
644	630		15
645	631		16
646	632		17
647	633		18
648	634		19
649	635		20
650	636		21
651	637		22
652	638		23
653	639		24
654	640
655		-	36. 38. “Medical marijuana product ” or “product” means a
656		-	product that contains cannabinoids that have be en extracted from
657		-	plant material or the resin therefrom by physical or chemical means
658		-	and is intended for administration to a qualified patient including,
659		-	but not limited to, oils, tinctures, edibles, pills, topical forms,
660	641		gels, creams, vapors, patches, liquids , and forms administered by a
661	642		nebulizer, excluding live plant forms which are consi dered medical
662	643		marijuana;
663	644		37. 39. “Medical marijuana processor ” means a person or entity
664	645		licensed pursuant to this act to operate a business including the
665	646		production, manufacture, extraction, processing, packaging or
666	647		creation of concentrate, medical -marijuana-infused products or
667	648		medical marijuana products as described in this act the Oklahoma
668	649		Medical Marijuana and Patient Protection Act ;
669	650		38. 40. “Medical marijuana res earch facility” or “research
670	651		facility” means a person or entity approved pursuant to this act the
671	652		Oklahoma Medical Marijuana and Patient Protectio n Act to conduct
672	653		medical marijuana research. A medical marijua na research facility
673	654		is not a medical marijuana business;
674	655		39. 41. “Medical marijuana testi ng laboratory” or “laboratory”
675	656		means a public or private laboratory licensed pursuant to this act
676	657		the Oklahoma Medical Marijuana and Patient Prot ection Act, to
677	658		conduct testing and research on medical marijuana and medical
678	659		marijuana products;
	660	+	40. 42. “Medical marijuana transporter” or “transporter” means
	661	+	a person or entity that is licensed pursuant to this act the
	662	+	Oklahoma Medical Marijuana and Patient Prote ction Act. A medical
	663	+	marijuana transporter does not include a medical marijuana business
	664	+	that transports its own medic al marijuana, medical marijuana
679	665
680		-	SB459 HFLR Page 14
681		-	BOLD FACE denotes Committee Amendments. 1
	666	+	ENGR. S. B. NO. 459 Page 14 1
682	667		2
683	668		3
684	669		4
685	670		5
686	671		6
687	672		7
688	673		8
689	674		9
690	675		10
691	676		11
692	677		12
693	678		13
694	679		14
695	680		15
696	681		16
697	682		17
698	683		18
699	684		19
700	685		20
701	686		21
702	687		22
703	688		23
704	689		24
705	690
706		-	40. 42. “Medical marijuana transporter ” or “transporter” means
707		-	a person or entity that is licensed pursuant to this act the
708		-	Oklahoma Medical Marijuana and Patient Protection Act . A medical
709		-	marijuana transporter does not includ e a medical marijuana business
710		-	that transports its own medical marijuana, medical marijuana
711	691		concentrate or medical marijuana products to a property or facility
712	692		adjacent to or connected to the licensed premises if the property is
713	693		another licensed premises of the same medical marijuana business;
714	694		41. 43. “Medical marijuana waste” or “waste” means unused,
715	695		surplus, returned or out-of-date marijuana, plant debris of the
716	696		plant of the genus Ca nnabis, including dead plants and all unused
717	697		plant parts and roots, except the term shall not include roots,
718	698		stems, stalks and fan l eaves;
719	699		42. 44. “Medical use” means the acquisition, possession, use,
720	700		delivery, transfer or transporta tion of medical marijuana, medical
721	701		marijuana products, medical marijuana devices or paraphernalia
722	702		relating to the administration of medical marijuana to t reat a
723	703		licensed patient;
724	704		43. 45. “Mother plant” means a marijuana plant that is grown or
725	705		maintained for the purpose of generating c lones, and that will not
726	706		be used to produce plant material for sale to a medical marijuana
727	707		processor or medical marijuana di spensary;
728	708		44. 46. “Oklahoma physician” or “physician” means a physician
729	709		licensed by and in good stand ing with the State Board of Medica l
	710	+	Licensure and Supervision, the State Board of Osteopathic Examiners
	711	+	or the Board of Podiatric Medical Examiners;
	712	+	45. 47. “Oklahoma resident” means an individual who can provide
	713	+	proof of residency as required by this act the Oklahoma Medical
	714	+	Marijuana and Patient Prote ction Act;
730	715
731		-	SB459 HFLR Page 15
732		-	BOLD FACE denotes Committee Amendments. 1
	716	+	ENGR. S. B. NO. 459 Page 15 1
733	717		2
734	718		3
735	719		4
736	720		5
737	721		6
738	722		7
739	723		8
740	724		9
741	725		10
742	726		11
743	727		12
744	728		13
745	729		14
746	730		15
747	731		16
748	732		17
749	733		18
750	734		19
751	735		20
752	736		21
753	737		22
754	738		23
755	739		24
756	740
757		-	Licensure and Supervision, the State Board of Osteopathic Examiners
758		-	or the Board of Podiatric Medical Examiners;
759		-	45. 47. “Oklahoma resident” means an individual who can provide
760		-	proof of residency as required by this act the Oklahoma Medical
761		-	Marijuana and Patient Protection Act ;
762	741		46. 48. “Owner” means, except where the context otherwise
763	742		requires, a direct beneficial owner includin g, but not limited to,
764	743		all persons or entities as follows:
765	744		a. all shareholders owning an interest of a corporate
766	745		entity and all officers of a c orporate entity,
767	746		b. all partners of a general part nership,
768	747		c. all general partners and all limited partners that own
769	748		an interest in a limited partnership,
770	749		d. all members that own an interest in a limited
771	750		liability company,
772	751		e. all beneficiaries that hold a beneficial interest in a
773	752		trust and all trustees of a trust,
774	753		f. all persons or entities that own interest in a joi nt
775	754		venture,
776	755		g. all persons or entities that own an interest in a n
777	756		association,
778	757		h. the owners of any ot her type of legal entity, and
	758	+	i. any other person holding an interest or convertible
	759	+	note in any entity which owns, operates or manages a
	760	+	licensed facility;
	761	+	47. 49. “Package” or “packaging” means any container or wrapp er
	762	+	that may be used by a medical mari juana business to enclose or
	763	+	contain medical marijuana;
779	764
780		-	SB459 HFLR Page 16
781		-	BOLD FACE denotes Committee Amendments. 1
	765	+	ENGR. S. B. NO. 459 Page 16 1
782	766		2
783	767		3
784	768		4
785	769		5
786	770		6
787	771		7
788	772		8
789	773		9
790	774		10
791	775		11
792	776		12
793	777		13
794	778		14
795	779		15
796	780		16
797	781		17
798	782		18
799	783		19
800	784		20
801	785		21
802	786		22
803	787		23
804	788		24
805	789
806		-	i. any other person holding an interest or convertible
807		-	note in any entity which owns, operates or manages a
808		-	licensed facility;
809		-	47. 49. “Package” or “packaging” means any container or wrapper
810		-	that may be used by a medical marijuana business to enclose or
811		-	contain medical marijuana;
812	790		48. 50. “Person” means a natural person, p artnership,
813	791		association, business trust, company, corpo ration, estate, limited
814	792		liability company, trust or any other lega l entity or organization,
815	793		or a manager, agent, owner, director, servant, office r or employee
816	794		thereof, except that “person” does not include any governmental
817	795		organization;
818	796		49. 51. “Pesticide” means any substance or mixture of
819	797		substances intended for prevent ing, destroying, repelling or
820	798		mitigating any pest or any substance or mixture o f substances
821	799		intended for use as a plant regulator, defolia nt or desiccant,
822	800		except that the term “pesticide” shall not include any article that
823	801		is a “new animal drug” as designated by the United States Food and
824	802		Drug Administration;
825	803		50. 52. “Production batch” means:
826	804		a. any amount of medical marijuana concentrate of th e
827	805		same category and produced using the same ext raction
828	806		methods, standard operating procedures and an
	807	+	identical group of harvest batch of medical mari juana,
	808	+	or
	809	+	b. any amount of medical marijuana product of the same
	810	+	exact type, produced using the same ingred ients,
	811	+	standard operating procedures and the sa me production
	812	+	batch of medical marijuana concentrate;
829	813
830		-	SB459 HFLR Page 17
831		-	BOLD FACE denotes Committee Amendments. 1
	814	+	ENGR. S. B. NO. 459 Page 17 1
832	815		2
833	816		3
834	817		4
835	818		5
836	819		6
837	820		7
838	821		8
839	822		9
840	823		10
841	824		11
842	825		12
843	826		13
844	827		14
845	828		15
846	829		16
847	830		17
848	831		18
849	832		19
850	833		20
851	834		21
852	835		22
853	836		23
854	837		24
855	838
856		-	identical group of harvest batch of medical marijuana,
857		-	or
858		-	b. any amount of medical marijuana product of the same
859		-	exact type, produced using the same ingredients,
860		-	standard operating procedures and the same production
861		-	batch of medical marijuana concentrate;
862	839		51. 53. “Public institution” means any entity established or
863	840		controlled by the federal govern ment, state government, or a local
864	841		government or municipality inc luding, but not limited to,
865	842		institutions of higher education or related research institutions;
866	843		52. 54. “Public money” means any funds or money o btained by the
867	844		holder from any governmental ent ity including, but not limited to,
868	845		research grants;
869	846		53. 55. “Recommendation” means a document that is sign ed or
870	847		electronically submitted by a physician on behalf of a patient fo r
871	848		the use of medical marijuana pursuant to this act the Oklahoma
872	849		Medical Marijuana and P atient Protection Act ;
873	850		54. 56. “Registered to conduct business ” means a person that
874	851		has provided proof th at the business applicant is in good standing
875	852		with the Oklahoma Secretary of State and Oklahoma Tax Co mmission;
876	853		55. 57. “Remediation” means the process by which the medical
877	854		marijuana flower or trim, which has failed microbial testing, is
878	855		processed into solvent-based medical marijuana concentrate and
	856	+	retested as required by this act the Oklahoma Medical Marijuana and
	857	+	Patient Protection Act ;
	858	+	56. 58. “Research project” means a discrete scientific endeavor
	859	+	to answer a research question or a set of research questions r elated
	860	+	to medical marijuana and is required for a medical marijuana
	861	+	research license. A research proj ect shall include a description of
	862	+	a defined protocol, clearly articulated goals, defined methods and
879	863
880		-	SB459 HFLR Page 18
881		-	BOLD FACE denotes Committee Amendments. 1
	864	+	ENGR. S. B. NO. 459 Page 18 1
882	865		2
883	866		3
884	867		4
885	868		5
886	869		6
887	870		7
888	871		8
889	872		9
890	873		10
891	874		11
892	875		12
893	876		13
894	877		14
895	878		15
896	879		16
897	880		17
898	881		18
899	882		19
900	883		20
901	884		21
902	885		22
903	886		23
904	887		24
905	888
906		-	retested as required by this act the Oklahoma Medical Marijuana and
907		-	Patient Protection Act ;
908		-	56. 58. “Research project” means a discrete scientific endeavor
909		-	to answer a research question or a set of research questions related
910		-	to medical marijuana and is required for a medical marijuana
911		-	research license. A research project shall include a description of
912		-	a defined protocol, clearly arti culated goals, defined methods and
913	889		outputs, and a defined start and end date. The desc ription shall
914	890		demonstrate that the research project will comply with all
915	891		requirements in this act the Oklahoma Medical Marijuana and Patient
916	892		Protection Act and rules promulgated pursuant thereto. All research
917	893		and development cond ucted by a medical marijuan a research facility
918	894		shall be conducted in furtherance of an approved research project;
919	895		57. 59. “Revocation” means the final decision by the Department
920	896		that any license issued pursuant to this act the Oklahoma Medical
921	897		Marijuana and Patient Protection Act is rescinded because the
922	898		individual or entity does not comply with the applicable
923	899		requirements set forth in this act the Oklahoma Medical Marijuana
924	900		and Patient Protection Act or rules promulgated pursuant thereto;
925	901		58. 60. “School” means a public or private preschool or a
926	902		public or private elementary or secondary school used for school
927	903		classes and instruction. A homeschool, daycare or child-care
928	904		facility shall not be considered a “school” as used in this act the
929	905		Oklahoma Medical Marijuana and Patient Protec tion Act;
	906	+	59. 61. “Shipping container” means a hard-sided container with
	907	+	a lid or other enclosure that can be secured in place. A shipp ing
	908	+	container is used solely for the transport of medi cal marijuana,
	909	+	medical marijuana concentrate, or medical marijuan a products between
	910	+	medical marijuana businesses, a medical marijuana research facility,
	911	+	or a medical marijuana education facility;
930	912
931		-	SB459 HFLR Page 19
932		-	BOLD FACE denotes Committee Amendments. 1
	913	+	ENGR. S. B. NO. 459 Page 19 1
933	914		2
934	915		3
935	916		4
936	917		5
937	918		6
938	919		7
939	920		8
940	921		9
941	922		10
942	923		11
943	924		12
944	925		13
945	926		14
946	927		15
947	928		16
948	929		17
949	930		18
950	931		19
951	932		20
952	933		21
953	934		22
954	935		23
955	936		24
956	937
957		-	59. 61. “Shipping container” means a hard-sided container with
958		-	a lid or other enclosure that can be secured in place. A shipping
959		-	container is used solely fo r the transport of medical marijuana,
960		-	medical marijuana concentrate, or medical marijuana products between
961		-	medical marijuana businesses, a medical marijuana research facility,
962		-	or a medical marijuana education facility;
963	938		60. 62. “Solvent-based medical marijuana concentrate ” means a
964	939		medical marijuana concentrate that was produced by extracting
965	940		cannabinoids from medical marijuana through the use of a solvent
966	941		approved by the Department;
967	942		61. 63. “State Question” means Oklahoma State Question No. 788,
968	943		Initiative Petition No. 412, approv ed by a majority vote of the
969	944		citizens of Oklahoma on June 26, 2 018;
970	945		62. 64. “Strain” means the classification of marijuana or
971	946		cannabis plants in either pure sativa, indica, afghanica, ruderalis
972	947		or hybrid varieties;
973	948		63. 65. “THC” means tetrahydrocannabinol, which is the primary
974	949		psychotropic cannabinoid in marijuana f ormed by decarboxylation of
975	950		naturally tetrahydrocannabinolic acid, which generally occurs by
976	951		exposure to heat;
977	952		64. 66. “Test batch” means with regard to usable marijuana, a
978	953		homogenous, identified quantity of usable marijuana by strain, no
979	954		greater than ten (10) pounds, that is harvested during a seven-day
980	955		period from a specified cultivation area, and with regard to oils,
	956	+	vapors and waxes derived from usable marijuana, means an identified
	957	+	quantity that is uniform, that is intended to meet specifications
	958	+	for identity, strength and composition, and that is manufactured,
	959	+	packaged and labeled during a specified time period according to a
	960	+	single manufacturing, packaging and labeling protocol;
981	961
982		-	SB459 HFLR Page 20
983		-	BOLD FACE denotes Committee Amendments. 1
	962	+	ENGR. S. B. NO. 459 Page 20 1
984	963		2
985	964		3
986	965		4
987	966		5
988	967		6
989	968		7
990	969		8
991	970		9
992	971		10
993	972		11
994	973		12
995	974		13
996	975		14
997	976		15
998	977		16
999	978		17
1000	979		18
1001	980		19
1002	981		20
1003	982		21
1004	983		22
1005	984		23
1006	985		24
1007	986
1008		-	vapors and waxes derived from usable marijuana, me ans an identified
1009		-	quantity that is uniform, that is intended to meet specifications
1010		-	for identity, strength and composition, and that is manufactured,
1011		-	packaged and labeled during a specified time period according to a
1012		-	single manufacturing, packaging and lab eling protocol;
1013	987		65. 67. “Transporter agent” means a person who transports
1014	988		medical marijuana or medical marijuana products for a licensed
1015	989		transporter and holds a transporter agent license pursuant to this
1016	990		act the Oklahoma Medical Marijuana and Patient Protection Act ;
1017	991		66. 68. “Universal symbol” means the image established by the
1018	992		State Department of Health or Oklahoma Medical Marijuana Authority
1019	993		and made available to licensees through its website indicating that
1020	994		the medical marijuana or the medical marijuana product contains THC;
1021	995		67. 69. “Usable marijuana” means the dried leaves, flowers,
1022	996		oils, vapors, waxes and other portions of the ma rijuana plant and
1023	997		any mixture or preparation thereof, excluding seed, roots, stems,
1024	998		stalks and fan leaves; and
1025	999		68. 70. “Water-based medical marijuana concentrate ” means a
1026	1000		concentrate that was produced by extract ing cannabinoids from
1027	1001		medical marijuana thro ugh the use of only water, ice, or dry ice.
1028	1002		SECTION 3. AMENDATORY Section 8, Chapter 11, O.S.L. 2019
1029	1003		(63 O.S. Supp. 2020, Section 427.8), is amended to read as follows:
1030	1004		Section 427.8. A. The rights to possess the marijuana product s
1031	1005		set forth in Section 420 of Title 63 of the Oklahoma Statutes this
	1006	+	title are cumulative and a duly licensed individual may possess at
	1007	+	any one time the totality of the items listed therein and not be in
	1008	+	violation of this act the Oklahoma Medical Marijuana and Patient
	1009	+	Protection Act so long as the individual holds a valid patient
	1010	+	license or caregiver license.
1032	1011
1033		-	SB459 HFLR Page 21
1034		-	BOLD FACE denotes Committee Amendments. 1
	1012	+	ENGR. S. B. NO. 459 Page 21 1
1035	1013		2
1036	1014		3
1037	1015		4
1038	1016		5
1039	1017		6
1040	1018		7
1041	1019		8
1042	1020		9
1043	1021		10
1044	1022		11
1045	1023		12
1046	1024		13
1047	1025		14
1048	1026		15
1049	1027		16
1050	1028		17
1051	1029		18
1052	1030		19
1053	1031		20
1054	1032		21
1055	1033		22
1056	1034		23
1057	1035		24
1058	1036
1059		-	title are cumulative and a duly licensed individual may possess at
1060		-	any one time the totality of the items listed therein and not be in
1061		-	violation of this act the Oklahoma Medical Marijuana and Patient
1062		-	Protection Act so long as the individual holds a valid patient
1063		-	license or caregiver license.
1064	1037		B. Municipal and county governing bodies may not enact medic al
1065	1038		marijuana guidelines which restrict or int erfere with the rights of
1066	1039		a licensed patient or caregiver to pos sess, purchase, cultivate or
1067	1040		transport medical marijuana within the legal limits set forth in
1068	1041		this act the Oklahoma Medical Marijuana and Patient Protection Act
1069	1042		or Section 420 et seq. of Title 63 of the Oklahoma Statutes this
1070	1043		title or require patients or caregivers to obtain permits or
1071	1044		licenses in addition to the state-required licenses provided herein.
1072	1045		C. Nothing in this act the M Oklahoma edical Marijuana and
1073	1046		Patient Protection Act or Section 420 et seq. of Title 63 of the
1074	1047		Oklahoma Statutes this title shall prohibit a residential or
1075	1048		commercial property or business owner from prohibiting the
1076	1049		consumption of medical marijuana or medical marijuana product by
1077	1050		smoke or vaporization on the premises, within the structures of the
1078	1051		premises or within ten (10) feet of the entryway to the premises .
1079	1052		However, a medical marijuana patient shall not be denied the right
1080	1053		to consume or use other medical marijuana p roducts which are
1081	1054		otherwise legal and do not invo lve the smoking or vaporization of
	1055	+	cannabis when lawfully recommended pursuant to Section 420 of Title
	1056	+	63 of the Oklahoma Statutes.
	1057	+	D. A medical marijuana patient or caregiver licensee shall not
	1058	+	be denied eligibility in public assistance programs includin g, but
	1059	+	not limited to, Medicaid, Supplemental Nutrition Assistance Program
	1060	+	(SNAP), Women, Infants, and Children Nutrition Program (WIC),
1082	1061
1083		-	SB459 HFLR Page 22
1084		-	BOLD FACE denotes Committee Amendments. 1
	1062	+	ENGR. S. B. NO. 459 Page 22 1
1085	1063		2
1086	1064		3
1087	1065		4
1088	1066		5
1089	1067		6
1090	1068		7
1091	1069		8
1092	1070		9
1093	1071		10
1094	1072		11
1095	1073		12
1096	1074		13
1097	1075		14
1098	1076		15
1099	1077		16
1100	1078		17
1101	1079		18
1102	1080		19
1103	1081		20
1104	1082		21
1105	1083		22
1106	1084		23
1107	1085		24
1108	1086
1109		-	cannabis when lawfully recommended pursuant to Section 420 of Title
1110		-	63 of the Oklahoma Statutes.
1111		-	D. A medical marijuana patient or c aregiver licensee shall not
1112		-	be denied eligibility in public assistance programs including, but
1113		-	not limited to, Medicaid, Supplemental Nutrition Assistance Program
1114		-	(SNAP), Women, Infants, and Children Nutrition Program (WIC),
1115	1087		Temporary Assistance for Needy Families (TANF) or other such public
1116	1088		assistance programs based solely on his or her stat us as a medical
1117	1089		marijuana patient or caregiver licensee, unless required by federal
1118	1090		law.
1119	1091		E. A medical marijuana patient or caregiver licensee shall not
1120	1092		be denied the right to own, purchase or possess a fire arm,
1121	1093		ammunition, or firearm accessories based sol ely on his or her status
1122	1094		as a medical marijuana patient or caregiver licensee. No state or
1123	1095		local agency, municipal or county governing authority shall
1124	1096		restrict, revoke, suspend or otherwise infringe upon th e right of a
1125	1097		person to own, purchase or possess a firearm, ammunition, or firearm
1126	1098		accessories or any related firearms license or certification based
1127	1099		solely on their status as a medical marijuana patient or caregiver
1128	1100		licensee.
1129	1101		F. A medical marijuana patien t or caregiver in actual
1130	1102		possession of a medical marijuana license shall not be subject to
1131	1103		arrest, prosecution or penalty in any manner or deni ed any right,
1132	1104		privilege or public assistance, under state law or municipal or
	1105	+	county ordinance or resolution incl uding without limitation a civil
	1106	+	penalty or disciplinary action by a business, occupational or
	1107	+	professional licensing board or bureau, for the medical use of
	1108	+	marijuana in accordance with this act the Oklahoma Medical Marijuana
	1109	+	and Patient Protection Act .
1133	1110
1134		-	SB459 HFLR Page 23
1135		-	BOLD FACE denotes Committee Amendments. 1
	1111	+	ENGR. S. B. NO. 459 Page 23 1
1136	1112		2
1137	1113		3
1138	1114		4
1139	1115		5
1140	1116		6
1141	1117		7
1142	1118		8
1143	1119		9
1144	1120		10
1145	1121		11
1146	1122		12
1147	1123		13
1148	1124		14
1149	1125		15
1150	1126		16
1151	1127		17
1152	1128		18
1153	1129		19
1154	1130		20
1155	1131		21
1156	1132		22
1157	1133		23
1158	1134		24
1159	1135
1160		-	county ordinance or resolution including without limitation a civil
1161		-	penalty or disciplinary action by a business, occupational or
1162		-	professional licensing board or bureau, for the medical use of
1163		-	marijuana in accordance with this act the Oklahoma Medical Marijuana
1164		-	and Patient Protection Act .
1165	1136		G. A government medical assistance program shall not be
1166	1137		required to reimburse a person for costs associated with the medical
1167	1138		use of marijuana unless federal law re quires reimbursement.
1168	1139		H. Unless otherwise required by federal law or required to
1169	1140		obtain federal fundi ng:
1170	1141		1. No employer may refuse to hire, discipline, discharge or
1171	1142		otherwise penalize an applicant or employee solely on the basis of
1172	1143		such applicant’s or employee’s status as a medical marijuana
1173	1144		licensee; and
1174	1145		2. No employer may refuse to hire, discipline, d ischarge or
1175	1146		otherwise penalize an applic ant or employee solely on the basis of a
1176	1147		positive test for marijuana components or metabolites, unless:
1177	1148		a. the applicant or employee is not in possession of a
1178	1149		valid medical marijuana license,
1179	1150		b. the licensee possesse s, consumes or is under the
1180	1151		influence of medical marijuana or medical marijuana
1181	1152		product while at the place of employment or during the
1182	1153		fulfillment of employment obligations, or
	1154	+	c. the position is one involving safety -sensitive job
	1155	+	duties, as such term is d efined in subsection K of
	1156	+	this section.
	1157	+	I. Nothing in this act the Oklahoma Medical Marijuana and
	1158	+	Patient Protection Act or Section 420 et seq. of Title 63 of the
	1159	+	Oklahoma Statutes this title shall:
1183	1160
1184		-	SB459 HFLR Page 24
1185		-	BOLD FACE denotes Committee Amendments. 1
	1161	+	ENGR. S. B. NO. 459 Page 24 1
1186	1162		2
1187	1163		3
1188	1164		4
1189	1165		5
1190	1166		6
1191	1167		7
1192	1168		8
1193	1169		9
1194	1170		10
1195	1171		11
1196	1172		12
1197	1173		13
1198	1174		14
1199	1175		15
1200	1176		16
1201	1177		17
1202	1178		18
1203	1179		19
1204	1180		20
1205	1181		21
1206	1182		22
1207	1183		23
1208	1184		24
1209	1185
1210		-	c. the position is one involvin g safety-sensitive job
1211		-	duties, as such term is defined in subsection K of
1212		-	this section.
1213		-	I. Nothing in this act the Oklahoma Medical Marijuana and
1214		-	Patient Protection Act or Section 420 et seq. of Title 63 of the
1215		-	Oklahoma Statutes this title shall:
1216	1186		1. Require an employer to permit or accommodate the use of
1217	1187		medical marijuana on the property or premises of any place of
1218	1188		employment or during hours of employment;
1219	1189		2. Require an employer, a government medical assistance
1220	1190		program, private health insurer, worker’s compensation carrier or
1221	1191		self-insured employer providin g worker’s compensation benefits to
1222	1192		reimburse a person for costs associated with the use of medical
1223	1193		marijuana; or
1224	1194		3. Prevent an employer from having written policies re garding
1225	1195		drug testing and impairment in accordance with the Oklahoma
1226	1196		Standards for Workplace Drug and Alcohol Testing Act, Section 551 et
1227	1197		seq. of Title 40 of the Oklahoma Statutes.
1228	1198		J. Any applicant or employee aggrieved by a willful violation
1229	1199		of this section shall have, as his or her exclusive remedy, the same
1230	1200		remedies as provided for in the Oklahoma Standards for Workplace
1231	1201		Drug and Alcohol Testing Act set forth in Section 563 of Title 40 of
1232	1202		the Oklahoma Statutes.
1233	1203		K. As used in this section:
	1204	+	1. “Safety-sensitive” means any job that includes tasks or
	1205	+	duties that the employer reasonably belie ves could affect the safety
	1206	+	and health of the employee performing the task or others including,
	1207	+	but not limited to, any of the following:
	1208	+	a. the handling, packaging, pro cessing, storage, disposal
	1209	+	or transport of hazardous materials,
1234	1210
1235		-	SB459 HFLR Page 25
1236		-	BOLD FACE denotes Committee Amendments. 1
	1211	+	ENGR. S. B. NO. 459 Page 25 1
1237	1212		2
1238	1213		3
1239	1214		4
1240	1215		5
1241	1216		6
1242	1217		7
1243	1218		8
1244	1219		9
1245	1220		10
1246	1221		11
1247	1222		12
1248	1223		13
1249	1224		14
1250	1225		15
1251	1226		16
1252	1227		17
1253	1228		18
1254	1229		19
1255	1230		20
1256	1231		21
1257	1232		22
1258	1233		23
1259	1234		24
1260	1235
1261		-	1. “Safety-sensitive” means any job that includ es tasks or
1262		-	duties that the employer reasonably believes could affect the safety
1263		-	and health of the employee performing the task or others including,
1264		-	but not limited to, any of the following:
1265		-	a. the handling, packaging, processing, storage, disposal
1266		-	or transport of hazardous materials,
1267	1236		b. the operation of a m otor vehicle, other vehicle,
1268	1237		equipment, machinery or power tools,
1269	1238		c. repairing, maintaining or monitoring the performance
1270	1239		or operation of any equipment, machinery or
1271	1240		manufacturing process, the malfunction or disruption
1272	1241		of which could result in injury or pr operty damage,
1273	1242		d. performing firefighting or law enforcement duties,
1274	1243		e. the operation, maintenance or oversight of critical
1275	1244		services and infrastructure including, but no t limited
1276	1245		to, electric, gas, and water utilities, power
1277	1246		generation or distribution,
1278	1247		f. the extraction, compression, processing,
1279	1248		manufacturing, handling, packaging, storage, disposal,
1280	1249		treatment or transport of potentially volatile,
1281	1250		flammable, combustible ma terials, elements, chemicals
1282	1251		or any other highly regulated component,
1283	1252		g. dispensing pharmaceuticals,
1284	1253		h. carrying a firearm, or
	1254	+	i. direct patient care, vulnerable or elderly adult care,
	1255	+	disabled or handicapped care or direct child care; and
	1256	+	2. A “positive test for marijuana components or metabolites”
	1257	+	means a result that is at or above the cutoff concentrat ion level
	1258	+	established by the United States Department of Transportat ion or
1285	1259
1286		-	SB459 HFLR Page 26
1287		-	BOLD FACE denotes Committee Amendments. 1
	1260	+	ENGR. S. B. NO. 459 Page 26 1
1288	1261		2
1289	1262		3
1290	1263		4
1291	1264		5
1292	1265		6
1293	1266		7
1294	1267		8
1295	1268		9
1296	1269		10
1297	1270		11
1298	1271		12
1299	1272		13
1300	1273		14
1301	1274		15
1302	1275		16
1303	1276		17
1304	1277		18
1305	1278		19
1306	1279		20
1307	1280		21
1308	1281		22
1309	1282		23
1310	1283		24
1311	1284
1312		-	i. direct patient care, vulnerable or elderly adult care,
1313		-	disabled or handicapped care or direct child care; and
1314		-	2. A “positive test for marijuana components or m etabolites”
1315		-	means a result that is at or above the cutoff concentration level
1316		-	established by the United States Department of Transportation or
1317	1285		Oklahoma law regarding being under the influence, whichever is
1318	1286		lower.
1319	1287		L. All smokable, vaporized, vapable and e-cigarette medical
1320	1288		marijuana product inhaled through vaporization or smoked by a
1321	1289		medical marijuana licensee are subject to the same restr ictions for
1322	1290		tobacco under Section 1 -1521 of Title 63 of the Oklahoma Statutes
1323	1291		this title, commonly referred to as the “Smoking in Public Places
1324	1292		and Indoor Workplaces Act ”.
1325	1293		SECTION 4. This act shall become effective November 1, 2021.
	1294	+	Passed the Senate the 9th day of March, 2021.
1326	1295
1327		-	COMMITTEE REPORT BY: COMMITTEE ON BUSINESS AND COMMERCE, dated
1328		-	04/07/2021 - DO PASS.
	1296	+
	1297	+
	1298	+	Presiding Officer of the Senate
	1299	+
	1300	+
	1301	+	Passed the House of Representatives the ____ day of __________,
	1302	+	2021.
	1303	+
	1304	+
	1305	+
	1306	+	Presiding Officer of the House
	1307	+	of Representatives
	1308	+